Published in Circ Cardiovasc Qual Outcomes on November 23, 2010
Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis. Circulation (2015) 1.66
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial. J Am Heart Assoc (2013) 1.26
Outcomes of anticoagulation therapy in patients with mental health conditions. J Gen Intern Med (2014) 0.94
Organizational characteristics of high- and low-performing anticoagulation clinics in the Veterans Health Administration. Health Serv Res (2012) 0.86
The business case for quality improvement: oral anticoagulation for atrial fibrillation. Circ Cardiovasc Qual Outcomes (2011) 0.86
Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial. J Am Heart Assoc (2015) 0.85
Limited English proficient patients and time spent in therapeutic range in a warfarin anticoagulation clinic. J Am Heart Assoc (2013) 0.83
Wide clinic-level variation in adherence to oral diabetes medications in the VA. J Gen Intern Med (2013) 0.83
High performing hospitals: a qualitative systematic review of associated factors and practical strategies for improvement. BMC Health Serv Res (2015) 0.83
The interplay of contextual elements in implementation: an ethnographic case study. BMC Health Serv Res (2015) 0.81
A Practical Guide to Using the Positive Deviance Method in Health Services Research. Health Serv Res (2016) 0.79
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice. J Am Heart Assoc (2015) 0.78
Utility of a dedicated pediatric cardiac anticoagulation program: the Boston Children's Hospital experience. Pediatr Cardiol (2015) 0.78
Newer anticoagulants for non-valvular atrial fibrillation. Pharmaceuticals (Basel) (2012) 0.77
Genetic determinants of variability in warfarin response after the dose-titration phase. Pharmacogenet Genomics (2016) 0.76
Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation. Ann N Y Acad Sci (2014) 0.76
The clinical impact of different coagulometers on patient outcomes. Adv Ther (2014) 0.75
An evaluation of intravenous vitamin k for warfarin reversal: are guideline recommendations being followed? Hosp Pharm (2015) 0.75
Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial. BMC Cardiovasc Disord (2016) 0.75
Capsule commentary on Paradise et al., Outcomes of anticoagulation therapy in patients with mental health conditions. J Gen Intern Med (2014) 0.75
Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management. Br J Clin Pharmacol (2016) 0.75
Potential use of NOACs in developing countries: pros and cons. Eur J Clin Pharmacol (2014) 0.75
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev (2004) 15.57
Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91
Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med (2002) 5.80
The "gender gap" in authorship of academic medical literature--a 35-year perspective. N Engl J Med (2006) 5.23
Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med (2008) 4.83
Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77
Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA (2003) 4.13
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation (2013) 3.25
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med (2012) 3.16
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med (2004) 3.06
The effectiveness of screening for prostate cancer: a nested case-control study. Arch Intern Med (2006) 2.97
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol (2013) 2.90
Racial differences in the prevalence of atrial fibrillation among males. J Natl Med Assoc (2008) 2.58
Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med (2003) 2.58
Identifying hypertension-related comorbidities from administrative data: what's the optimal approach? Am J Med Qual (2004) 2.47
Disparities in diabetes care: impact of mental illness. Arch Intern Med (2005) 2.45
Hypertension management in patients with diabetes: the need for more aggressive therapy. Diabetes Care (2003) 2.35
Self-reported vs administrative race/ethnicity data and study results. Am J Public Health (2002) 2.32
Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Med Care (2005) 2.28
Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med (2007) 2.16
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15
Do variations in disease prevalence limit the usefulness of population-based hospitalization rates for studying variations in hospital admissions? Med Care (2005) 2.13
Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension (2008) 2.10
Screening and brief intervention online for college students: the ihealth study. Alcohol Alcohol (2006) 2.06
Capture-recapture estimates of nonfatal workplace injuries and illnesses. Ann Epidemiol (2008) 2.05
Evidence-based tool for triggering school closures during influenza outbreaks, Japan. Emerg Infect Dis (2009) 2.02
Racial and ethnic differences in end-of-life costs: why do minorities cost more than whites? Arch Intern Med (2009) 2.02
Researcher judgment and study design: challenges of using administrative data. Am J Ind Med (2010) 1.98
Blood pressure and survival in the oldest old. J Am Geriatr Soc (2007) 1.98
Cancer survivorship and sexual orientation. Cancer (2011) 1.89
Ascertainment of Testosterone Prescribing Practices in the VA. Med Care (2015) 1.89
Characterization of activities of daily living in individuals with mild cognitive impairment. Am J Geriatr Psychiatry (2008) 1.86
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood (2009) 1.84
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. Am Heart J (2010) 1.82
A family longevity selection score: ranking sibships by their longevity, size, and availability for study. Am J Epidemiol (2009) 1.81
Do age and comorbidity affect intensity of pharmacological therapy for poorly controlled diabetes mellitus? J Am Geriatr Soc (2005) 1.78
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. Am Heart J (2011) 1.72
Hypertensive patients' race, health beliefs, process of care, and medication adherence. J Gen Intern Med (2007) 1.69
Measuring the quality of depression care in a large integrated health system. Med Care (2003) 1.69
The use of vertebral augmentation and external beam radiation therapy in the multimodal management of malignant vertebral compression fractures. Pain Physician (2011) 1.67
Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation (2005) 1.66
Faculty self-reported experience with racial and ethnic discrimination in academic medicine. J Gen Intern Med (2004) 1.64
Why are a quarter of faculty considering leaving academic medicine? A study of their perceptions of institutional culture and intentions to leave at 26 representative U.S. medical schools. Acad Med (2012) 1.61
The representation of women on the editorial boards of major medical journals: a 35-year perspective. Arch Intern Med (2008) 1.60
How do providers assess antihypertensive medication adherence in medical encounters? J Gen Intern Med (2006) 1.58
Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's. BMC Health Serv Res (2008) 1.56
Developing a quality measure for clinical inertia in diabetes care. Health Serv Res (2005) 1.56
Using administrative data to identify mental illness: what approach is best? Am J Med Qual (2009) 1.54
Hypertension control: how well are we doing? Arch Intern Med (2003) 1.53
Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc (2006) 1.51
Can primary care visits reduce hospital utilization among Medicare beneficiaries at the end of life? J Gen Intern Med (2008) 1.47
Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers. Cancer (2010) 1.46
Quality improvement implementation in the nursing home. Health Serv Res (2003) 1.45
Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis. Thromb Haemost (2011) 1.45
Palliation of compression fractures in cancer patients by vertebral augmentation: a retrospective analysis. J Neurointerv Surg (2010) 1.45
Patient safety in geriatrics: a call for action. J Gerontol A Biol Sci Med Sci (2003) 1.43
Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin. Thromb Haemost (2015) 1.42
Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population. Chest (2005) 1.41
Evaluating elements of executive functioning as predictors of instrumental activities of daily living (IADLs). Arch Clin Neuropsychol (2006) 1.40
Composite model for profiling physicians across domains of care. J Healthc Manag (2014) 1.39
Stroke prevention in atrial fibrillation: current status and near-future directions. Am J Med (2011) 1.39
Clinical Operations Variables are Associated With Blood Pressure Outcomes. Med Care (2015) 1.38
Decisional capacity for research participation in individuals with mild cognitive impairment. J Am Geriatr Soc (2008) 1.35
Genetic testing for warfarin dosing? Not yet ready for prime time. Pharmacotherapy (2008) 1.35
Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure. J Manag Care Pharm (2006) 1.35
Racial and ethnic differences in hospice use among patients with heart failure. Arch Intern Med (2010) 1.34
Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology (2010) 1.33
Barriers to hypertension control. Am Heart J (2005) 1.32
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol (2008) 1.31
The IL12B gene is associated with asthma. Am J Hum Genet (2004) 1.29
Understanding uncontrolled hypertension: is it the patient or the provider? J Clin Hypertens (Greenwich) (2007) 1.27
Cognitive correlates of HVOT performance differ between individuals with mild cognitive impairment and normal controls. Arch Clin Neuropsychol (2006) 1.26
Intensifying therapy for hypertension despite suboptimal adherence. Hypertension (2009) 1.22
Nursing home assessment of cognitive impairment: development and testing of a brief instrument of mental status. J Am Geriatr Soc (2008) 1.21
Sex differences in inappropriate prescribing among elderly veterans. Am J Geriatr Pharmacother (2007) 1.20
Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Thromb Thrombolysis (2003) 1.20
Substance use among Asian Americans and Pacific Islanders sexual minority adolescents: findings from the National Longitudinal Study of Adolescent Health. J Adolesc Health (2008) 1.20
Racial/ethnic differences in diabetes care for older veterans: accounting for dual health system use changes conclusions. Med Care (2006) 1.20
Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis Rheum (2007) 1.20
The health status of elderly veteran enrollees in the Veterans Health Administration. J Am Geriatr Soc (2004) 1.19
National assessment of warfarin anticoagulation therapy for stroke prevention in atrial fibrillation. Circulation (2014) 1.19
Can we use automated data to assess quality of hypertension care? Am J Manag Care (2004) 1.17
Disparities by race, ethnicity, and sex in treating acute coronary syndromes. J Womens Health (Larchmt) (2011) 1.17
The risk of hemorrhage among patients with warfarin-associated coagulopathy. J Am Coll Cardiol (2006) 1.16
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation. J Am Heart Assoc (2013) 1.15
Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. Am Heart J (2013) 1.14
Potentially inappropriate prescribing for the elderly: effects of geriatric care at the patient and health care system level. Med Care (2008) 1.13